TITLE

HCV and HIV Counseling and Testing Integration in California: An Innovative Approach to Increase HIV Counseling and Testing Rates

AUTHOR(S)
Stopka, Thomas J.; Marshall, Clark; Bluthenthal, Ricky N.; Webb, David S.; Truax, Steven R.
PUB. DATE
May 2007
SOURCE
Public Health Reports;May/Jun2007 Supplement, Vol. 122, p68
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives. In California, injection drug users (IDUs) comprise the second leading risk group for human immunodeficiency virus (HIV) infection and the majority of hepatitis C virus (HCV) cases. Innovative disease screening and prevention activities are needed to improve disease surveillance and to guide appropriate public health responses. This study tested the hypothesis that offering HIV counseling and testing (C&T) concurrently with HCV C&T will increase HIV C&T rates among IDUs. Methods. From February through June 2003, HIV and HCV C&T were integrated in five California local health jurisdictions. HIV C&T and disclosure rates among IDUs were monitored when HIV C&T was offered alone during a baseline phase and when offered with HCV C&T during an intervention phase. Results. Among IDUs, HIV C&T rates were significantly higher when HIV and HCV C&T were offered together (27.1%, 354/1,305) than when HIV C&T services were offered alone (8.4%, 138/1,645) (p<0.05). HIV disclosure rates increased from 54.3% (75/138) when only HIV test results were disclosed to 71.8% (254/354) when HIV test results were disclosed concurrently with HCV test results (p<0.05). HCV prevalence among IDUs tested ranged from 23% to 75% at the five project sites. Integrating HIV and HCV C&T increased overall C&T time required for staff and clients and increased stress among counselors due to the number of positive test results (HCV) given to clients. Conclusions. Study results suggest that integrating HIV and HCV C&T can increase disease screening rates among IDUs. Careful planning of integrated staff activities and schedules is recommended.
ACCESSION #
24833649

 

Related Articles

  • EVALUAREA PRIN METODE NONINVAZIVE A FIBROZEI HEPATICE LA PACIENÅ¢II CU COINFECÅ¢IE VHC-HIV UTILIZATORI DE DROGURI PE CALE INTRAVENOASÄ‚. Lazăr, Ştefan; Chiriţă, Daniel; Oprea, Cristiana; Drăghici, Loredana; Obretin, Dana; Tudor, Nicoleta; Ceauşu, Emanoil // Romanian Journal of Infectious Diseases;2014, Vol. 17 Issue 3, p158 

    Introduction. Coinfection of the hepatic C virus with the human immunodeficiency virus (HIV) in intravenous drug users (UDI) represents an important public health problem because of the big and increasing number of patients and the diagnostic, monitoring and treatment related challenges....

  • Reply. Rimland, David; Guest, Jodie L.; Marston, Barbara // Clinical Infectious Diseases;2/1/2000, Vol. 30 Issue 2, p410 

    Responds to comments on a report by C.T. Staples and colleagues, which dealt with hepatitis C virus coinfection. HIV-infection risk factor; Prevalence of both intravenous drug abuse and hepatitis C virus infection.

  • Factors associated with HIV and hepatitis C infection among regular and non-regular injection drug users in Baltimore. Graham, C. M.; Severtson, S. G.; Mitchell, M. M.; Floyd, L.; Latimer, W. W. // Retrovirology;2006 Supplement 1, Vol. 3, pP21 

    The article examines the association of HIV and hepatitis C infection prevalence and the length of time of regular injection drug use in Baltimore, Maryland. Regular users of intravenous drugs were more likely to be infected with hepatitis C virus (HCV) or HIV compared to short term injectors....

  • Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. Poulin, Céline; Alary, Michel; Lambert, Gilles; Godin, Gaston; Landry, Suzanne; Gagnon, Hélène; Demers, Éric; Morarescu, Elena; Rochefort, Jean; Claessens, Christiane // CMAJ: Canadian Medical Association Journal Supplement;7/31/2007, Vol. 177 Issue 3, p252 

    Background: To determine the prevalence of HIV and hepatitis C virus (HCV) infections and examine risk factors for these infections among inmates in Quebec provincial prisons. Methods: Anonymous cross-sectional data were collected from January to June 2003 for men (n= 1357) and women (n= 250)...

  • Neuropsychiatric Complications of Injection-Associated Diseases: HIV and Hepatitis C. Rado, Jeffrey // Psychiatric Annals;Jan2017, Vol. 47 Issue 1, p38 

    Intravenous use of illicit substances increases the risk for transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Both of these infections develop into chronic medical conditions with high morbidity and mortality. HIV and HCV may lead to significant neuropsychiatric...

  • Rapid Hepatitis C Testing Among Persons at Increased Risk for Infection -- Wisconsin, 2012-2013. Stockman, Lauren J.; Guilfoyle, Sheila M.; Benoit, Andrea L.; Vergeront, James M.; Davis, Jeffrey P. // MMWR: Morbidity & Mortality Weekly Report;4/11/2014, Vol. 63 Issue 14, p309 

    The article discusses the results of a rapid hepatitis C virus (HCV) test conducted for persons at increased risk for infection in Wisconsin from 2012 to 2013. The results include the demographic characteristics of persons who received the test. Injection drug use was found as the most common...

  • Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran. Kassaian, Nazila; Adibi, Peyman; Kafashaian, Alireza; Yaran, Majid; Nokhodian, Zary; Shoaei, Parisa; Hassannejad, Razieh; Babak, Anahita; Ataei, Behrooz // International Journal of Preventive Medicine;Mar2012 Supplement, Vol. 3, pS156 

    Objectives: Hepatitis C virus (HCV) infection is a major public health problem worldwide with serious complications. According to the importance of intravenous drug use (IDU) as the main risk factor for HCV infection and transmission and prison as the main source of risky behaviors, this study...

  • The curability of hepatitis C: Implications for a public health response. Krajden, Mel; Montaner, Julio S. G. // British Columbia Medical Journal;Jun2013, Vol. 55 Issue 5, p243 

    The article focuses on the need for a proactive public health response for a potential for near universal curability of hepatitis C virus (HC) infection. It relates the number of Canadians with chronic HCV. Some of the causes of HCV infections include injection drug use, high-risk sexual...

  • Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. White, Emily Faye; Garfein, Richard S.; Brouwer, Kimberly C.; Lozada, Remedios; Ramos, Rebeca; Firestone-Cruz, Michelle; Pérez, Saida G.; Magis-Rodríguez, Carlos; Conde-Glez, Carlos J.; Strathdee, Steffanie A. // Salud Pública de México;may/jun2007, Vol. 49 Issue 3, p165 

    Objective. To estimate the prevalence of the hepatitis C virus (HCV) and HIV infection and associated risk behaviors among injection drug users (IDUs) in two northern Mexican cities. Material and Methods. Between February and April 2005, IDUs were recruited in Tijuana (N=222) and Ciudad Juarez...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics